MedTrace Logo

Boston Alcohol Research Collaboration on HIV/AIDS (ARCH) Cohort

NCT01740115 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2016-09-12

No results posted yet for this study

Summary

The purpose of this study is to expand and continue a cohort of HIV-infected adults to establish the longitudinal Boston ARCH Cohort of 250 HIV-infected men and women with current substance dependence or ever injection drug use that have a spectrum of alcohol use; and to determine the effect of alcohol consumption on changes in bone health prospectively in the Cohort.

Conditions

  • HIV Infection
  • Alcohol Use
  • Bone Disease
  • Substance-Related Disorders

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Boston Medical Center

    lead OTHER

Principal Investigators

  • Richard Saitz, MD, MPH · Boston Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2016-03-31
Completion
2016-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01740115 on ClinicalTrials.gov